Page last updated: 2024-12-05

dichloralantipyrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dichloralantipyrine: 1:2 compound of antipyrine with chloral hydrate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10188
CHEMBL ID1697834
SCHEMBL ID115159
MeSH IDM0050481

Synonyms (36)

Synonym
sominat
dormuphar
einecs 207-546-0
sedor
antipyrine, compound with chloral hydrate (1:2)
ibiodorm
kloralfenazon
welldorm
dichloralantipyrin
1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one, compound with 2,2,2-trichloroethane-1,1-diol (1:2)
dichloralantipyrine
1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one - 2,2,2-trichloroethane-1,1-diol (1:2)
D03785
dichloralphenazone (usp)
480-30-8
dichloralphenazone
DB01495
dichloralphenazone civ
CHEMBL1697834
yyx637r279 ,
unii-yyx637r279
dichloralphenazone [usp:inn:ban]
dichloralphenazone [who-dd]
dichloralphenazone [mart.]
dichloralphenazone [vandf]
dichloralphenazone [usp impurity]
dichloralphenazone civ [usp-rs]
dichloralphenazone [mi]
SCHEMBL115159
DTXSID2022919
1,5-dimethyl-2-phenyl-1h-pyrazol-3(2h)-one compound with 2,2,2-trichloroethane-1,1-diol (1:2)
1,5-dimethyl-2-phenylpyrazol-3-one;2,2,2-trichloroethane-1,1-diol
Q5272471
FT-0750065
EN300-12624270
1,5-dimethyl-2-phenyl-2,3-dihydro-1h-pyrazol-3-one; bis(2,2,2-trichloroethane-1,1-diol)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (78.57)18.7374
1990's1 (7.14)18.2507
2000's2 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.48 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (21.43%)5.53%
Reviews1 (7.14%)6.00%
Case Studies3 (21.43%)4.05%
Observational0 (0.00%)0.25%
Other7 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]